-
Je něco špatně v tomto záznamu ?
Structures of human cytosolic and mitochondrial nucleotidases: implications for structure-based design of selective inhibitors
P. Pachl, M. Fábry, I. Rosenberg, O. Simák, P. Rezáčová, J. Brynda,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- cytosol chemie enzymologie MeSH
- deoxyribonukleotidy chemie MeSH
- Escherichia coli genetika metabolismus MeSH
- eukaryotické buňky chemie enzymologie MeSH
- fosfáty chemie MeSH
- inhibitory enzymů chemie MeSH
- izoenzymy antagonisté a inhibitory chemie genetika MeSH
- katalytická doména MeSH
- konformace proteinů MeSH
- krystalografie rentgenová MeSH
- lidé MeSH
- mitochondrie chemie enzymologie MeSH
- molekulární modely MeSH
- nukleotidasy antagonisté a inhibitory chemie genetika MeSH
- organofosfonáty chemie MeSH
- orgánová specificita MeSH
- racionální návrh léčiv MeSH
- rekombinantní proteiny chemie genetika MeSH
- simulace molekulového dockingu MeSH
- vztahy mezi strukturou a aktivitou MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
The human 5'(3')-deoxyribonucleotidases catalyze the dephosphorylation of deoxyribonucleoside monophosphates to the corresponding deoxyribonucleosides and thus help to maintain the balance between pools of nucleosides and nucleotides. Here, the structures of human cytosolic deoxyribonucleotidase (cdN) at atomic resolution (1.08 Å) and mitochondrial deoxyribonucleotidase (mdN) at near-atomic resolution (1.4 Å) are reported. The attainment of an atomic resolution structure allowed interatomic distances to be used to assess the probable protonation state of the phosphate anion and the side chains in the enzyme active site. A detailed comparison of the cdN and mdN active sites allowed the design of a cdN-specific inhibitor.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15008305
- 003
- CZ-PrNML
- 005
- 20150310111444.0
- 007
- ta
- 008
- 150306s2014 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1107/S1399004713030502 $2 doi
- 035 __
- $a (PubMed)24531480
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Pachl, Petr $u Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo nám. 2, 166 37 Prague 6, Czech Republic.
- 245 10
- $a Structures of human cytosolic and mitochondrial nucleotidases: implications for structure-based design of selective inhibitors / $c P. Pachl, M. Fábry, I. Rosenberg, O. Simák, P. Rezáčová, J. Brynda,
- 520 9_
- $a The human 5'(3')-deoxyribonucleotidases catalyze the dephosphorylation of deoxyribonucleoside monophosphates to the corresponding deoxyribonucleosides and thus help to maintain the balance between pools of nucleosides and nucleotides. Here, the structures of human cytosolic deoxyribonucleotidase (cdN) at atomic resolution (1.08 Å) and mitochondrial deoxyribonucleotidase (mdN) at near-atomic resolution (1.4 Å) are reported. The attainment of an atomic resolution structure allowed interatomic distances to be used to assess the probable protonation state of the phosphate anion and the side chains in the enzyme active site. A detailed comparison of the cdN and mdN active sites allowed the design of a cdN-specific inhibitor.
- 650 _2
- $a katalytická doména $7 D020134
- 650 _2
- $a krystalografie rentgenová $7 D018360
- 650 _2
- $a cytosol $x chemie $x enzymologie $7 D003600
- 650 _2
- $a deoxyribonukleotidy $x chemie $7 D003854
- 650 _2
- $a racionální návrh léčiv $7 D015195
- 650 _2
- $a inhibitory enzymů $x chemie $7 D004791
- 650 _2
- $a Escherichia coli $x genetika $x metabolismus $7 D004926
- 650 _2
- $a eukaryotické buňky $x chemie $x enzymologie $7 D005057
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a izoenzymy $x antagonisté a inhibitory $x chemie $x genetika $7 D007527
- 650 _2
- $a mitochondrie $x chemie $x enzymologie $7 D008928
- 650 _2
- $a molekulární modely $7 D008958
- 650 _2
- $a simulace molekulového dockingu $7 D062105
- 650 _2
- $a nukleotidasy $x antagonisté a inhibitory $x chemie $x genetika $7 D009708
- 650 _2
- $a orgánová specificita $7 D009928
- 650 _2
- $a organofosfonáty $x chemie $7 D063065
- 650 _2
- $a fosfáty $x chemie $7 D010710
- 650 _2
- $a konformace proteinů $7 D011487
- 650 _2
- $a rekombinantní proteiny $x chemie $x genetika $7 D011994
- 650 _2
- $a vztahy mezi strukturou a aktivitou $7 D013329
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Fábry, Milan $u Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo nám. 2, 166 37 Prague 6, Czech Republic.
- 700 1_
- $a Rosenberg, Ivan $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo nám. 2, 166 37 Prague 6, Czech Republic.
- 700 1_
- $a Simák, Ondřej $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo nám. 2, 166 37 Prague 6, Czech Republic.
- 700 1_
- $a Rezáčová, Pavlína $u Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo nám. 2, 166 37 Prague 6, Czech Republic.
- 700 1_
- $a Brynda, Jiří $u Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo nám. 2, 166 37 Prague 6, Czech Republic.
- 773 0_
- $w MED00179510 $t Acta crystallographica. Section D, Biological crystallography. Biological crystallography $x 1399-0047 $g Roč. 70, č. Pt 2 (2014), s. 461-70
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/24531480 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20150306 $b ABA008
- 991 __
- $a 20150310111721 $b ABA008
- 999 __
- $a ok $b bmc $g 1065578 $s 891105
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 70 $c Pt 2 $d 461-70 $i 1399-0047 $m Acta crystallographica. Section D, Biological crystallography $n Acta Crystallogr D Biol Crystallogr $x MED00179510 $o Biological crystallography
- LZP __
- $a Pubmed-20150306